• Explore /
  • Poster
  • / PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).

Abstract Poster

Authors

null

Lauren Christine Harshman

Dana-Farber Cancer Institute, Boston, MA

Lauren Christine Harshman , Maneka Puligandla , Naomi B. Haas , Mohamad Allaf , Charles G. Drake , David F. McDermott , Sabina Signoretti , David Cella , Rajan T. Gupta , Brian M. Shuch , Toni K. Choueiri , Primo Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Michael A.S. Jewett , Viraj A. Master , M. Dror Michaelson , Bradley C. Leibovich , Deb Maskens , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT03055013

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS684)

DOI

10.1200/JCO.2019.37.7_suppl.TPS684

Abstract #

TPS684

Poster Bd #

K15

Abstract Disclosures

Similar Posters

First Author: Lauren Christine Harshman

First Author: Naomi B. Haas

First Author: Lauren Christine Harshman

First Author: Mohamad E. Allaf